The 61st annual conference will contemplate and celebrate 100 years of mass spectrometry through special exhibits, sessions, and posters. Every registrant attending the conference will receive a memorable gift.
More than 9,000 microbiologists from around the world will gather to experience the Breadth. Vision. Impact. of asm2013.The renovated format of ASM’s General Meeting continues to gain momentum for the third consecutive year.
Join compelling conversations about your business challenges. Choose from 125+ sessions along 15 topic areas. Gain new perspectives from global thought leaders. Get up to date on policies, regulation, marketing and innovations.Learn better practices for business development, finance, manufacturing, and more.
Experimental Biology 2013 is on track to be one of the largest to date! Scientists and researchers in the fields of: anatomy, physiology, biochemistry, pathology, nutrition, and pharmacology will meet in Boston to discuss the strides and contributions made to the field of science.
Meet with more than 10,000 chemists, academics, students, and other professionals to address one of the most important issues of our time: The relationship between chemistry and food in our society.
It has been said around the world that the AACR Annual Meeting drives the cancer agenda. The meeting will once again highlight the latest and most exciting discoveries in every area of cancer research and provide a unique opportunity for investigators from all over the world to meet and forge collaborations.
Co-sponsored by the Spectroscopy Society of Pittsburgh and the Society for Analytical Chemists of Pittsburgh, Pittcon is the premier annual conference and exposition on laboratory science.
The Academy's annual scientific meeting is held in February at which time over 800 scientific papers, breakfast seminars, workshops, and other special events are presented. The AAFS consists of eleven sections representing a wide range of forensic specialties, and the annual scientific meeting gathers these professionals who present the most current information, research, and updates in this expanding field.
SLAS2013 is the Second Annual SLAS Conference and Exhibition. SLAS2013 will be held January 12-16, 2013, at the Gaylord Palms Resort and Convention Center in Orlando, FL, USA. This five-day event brings together scientists, academicians, business leaders and students from around the globe to gain new information, ideas and insight about laboratory science and technology.
Analysis of one- to four-microliter size samples for nucleic acids has become routine in many life science laboratories. However, until now, available instruments require considerable manipulation of the instrument and sample; some require manually recording the data. The user must typically lower and raise the arm manually, then wipe the sample manually from the target after each analysis. And fiberoptics used in some of these instruments are subject to deterioration.
While well-understood, robust and convenient, classical batch-style 2-D culture on non-porous supports or 3-D suspension culture in other devices are really not very biologically relevant models. Cell culture conditions can affect the quality of the antibody or protein produced.
Drug discovery and testing, with their need for speed, repeatability and verification, are ideally suited to benefit from robot automation. It is therefore not surprising that robots have been at the forefront of automation developments in both these areas.
Life sciences research today is advancing exponentially, each step bringing us closer to the realization of truly personalized medicine–preventive care and treatments designed specifically for each individual. In the near future, PCPGM healthcare researchers expect to be able to use predictive genetic testing to create custom treatment plans for individuals and deliver dramatic improvements over today’s one-size-fits-all approach. But research capabilities are only part of the equation; current storage and operating capacities must also evolve to accommodate ever-expanding amounts of data before the goal of personalized medicine can be realized.
Over the years, polymerase chain reaction (PCR) has evolved into a readily automated, high throughput quantitative technology. Real-time quantitative PCR (qPCR) has become the industry standard for the detection and quantification of nucleic acids for multiple application, including quantification of RNA levels. But a lack of consensus among researchers on how to best perform and interpret qPCR experiments presents a major hurdle for advancement of the technology. This problem is exacerbated by insufficient experimental detail in published work, which impedes the ability of others to accurately evaluate or replicate reported results.
The year 2009 was marked by the emergence of a novel influenza A (H1N1) virus that infects humans. There is a need to identify the different strains of influenza virus for purposes of monitoring the H1N1 strain pandemic and for other epidemiological and scientific purposes.